Dualitas Therapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
681 Gateway Blvd Ste 411, South San Fran...Website
www.dualitastx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Dualitas Therapeutics
Dualitas Therapeutics, Inc. is a biotechnology company pioneering next-generation bispecific antibody (BsAb) therapies for immunology and inflammation (I&I). Dualitas' portfolio, built from its DualScreen discovery engine, includes lead programs DTX-103 in allergic disease and DTX-102 in autoimmune disease, with numerous other discoveries based on cell-surface proximity biology and novel co-target pairing. While advancing its own pipeline, Dualitas offers a variety of strategic collaboration opportunities to extend the impact of its DualScreen discovery engine, ranging from existing pipeline programs to identifying de novo BsAbs, to establishing programs in disease areas beyond I&I.Explore more
Dualitas Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dualitas Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Dualitas Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Dualitas Therapeutics
Click to see if Dualitas Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Dualitas Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Dualitas Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Dualitas Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Dualitas Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Dualitas Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined Dualitas Therapeutics as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Dualitas Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Dualitas Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Dualitas Therapeutics.
Dualitas Therapeutics financials insights
Gather financial insights about Dualitas Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$65M
Dualitas Therapeutics Tech Stack
A closer look at the technologies used by Dualitas Therapeutics
See more technologies
Dualitas Therapeutics News & Media
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dualitas Therapeutics
Sign Up For FreeTo access detailed company insights
Dualitas Therapeutics, Inc. is a biotechnology company pioneering next-generation bispecific antibody (BsAb) therapies for immunology and inflammation (I&I). Dualitas' portfolio, built from its DualScreen discovery engine, includes lead programs DTX-103 in allergic disease and DTX-102 in autoimmune disease, with numerous other discoveries based on... Read More
